News
1d
The Punch on MSNSickle cell disease and knee joint pain: Why steriods aren’t always the best optionFor people living with sickle cell disease, joint pain, especially in the knees, can be a frustrating and persistent ...
Individuals with both sickle cell disease (SCD) and sickle cell trait are at higher risk than others of developing renal medullary cancer (RMC), the rarest and deadliest subtype of kidney cancer.
Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
Race has no biological basis and no effect on the onset or progression of disease.
While the medical world is melting down from the absolute apocalypse that is RFK Jr., it's good to celebrate that (at least ...
11h
The Punch on MSNWould you love to donate your organs after death?Organ transplantation represents one of the most remarkable achievements of modern medicine. Yet, in countries like Nigeria, ...
7d
Khaleej Times on MSNHajj in Saudi: 1 dead, 99 pilgrims infected with pneumoniaWhile Saudi authorities have not mandated Pneumococcal vaccine, they recommend that pilgrims aged 65 and over get this ...
10d
Barchart on MSNVertex Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish?With a market cap of $114.8 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company specializing in ...
In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...
The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results